Connor, Clark & Lunn Investment Management Ltd. Lensar, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$5.9 - $7.84 $503,576 - $669,159	-85,352 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.5 - $8.88 $593,385 - $702,567	-79,118 Reduced 48.1%	85,352 $672,000
Q4 2020 Feb 16, 2021	BUY	$6.7 - $12.2 $1.1 Million - $2.01 Million	164,470 New	164,470 $1.19 Million

Others Institutions Holding LNSR

# of Institutions

Shares Held

4.83M

Call Options Held

500

Put Options Held

49K

North Run Capital, LP Wellesley, MA

1.1M
Shares

$4.87 Million
7.54% of portfolio
Park West Asset Management LLC Larkspur, CA

973K
Shares

$4.32 Million
0.35% of portfolio
Dimensional Fund Advisors LP Austin, TX

657K
Shares

$2.92 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

433K
Shares

$1.92 Million
0.0% of portfolio
Brandes Investment Partners, LP La Jolla, CA

373K
Shares

$1.66 Million
0.02% of portfolio

View Full List

About LENSAR, Inc.

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $48.9M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

More about LNSR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account